"Kytopen's Flowfect (R) technology represents an exciting advancement in non-viral cellular engineering, and we're eager to explore how it could complement our donor-to-dose expertise," said Tom ...
Cell Impact AB and thyssenkrupp Automation Engineering just inked a strategic cooperation agreement in Karlskoga, Sweden on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback